(Q33402830)

English

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

scientific article

Statements

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial (English)
0 references
Anna Maria Di Giacomo
Lorenzo Pilla
Antonella Marasco
Stefania Vl Nicoletti
Ester Fonsatti
Diego Annesi
Alessandro Testori
Ruggero Ridolfi
Giorgio Parmiani

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit